IDWeek 研究:HPV 疫苗 9 至 10 岁启动较 11 至 12 岁提高 13 岁前接种起始与完成率
IDSA: Earlier introduction of HPV vaccine improves initiation, completion by age 13
IDWeek 报告的一项集群随机试验显示,将 HPV 疫苗启动年龄从 11 至 12 岁提前到 9 至 10 岁,13 岁前起始率和完成率均更高。13 岁前起始率分别为 77.1% 和 67.0%,完成率分别为 61.6% 和 45.1%。该试验 2021 至 2026 年在科罗拉多和加利福尼亚的 31 家儿科诊所开展,研究团队认为降低接种年龄有助于扩大 HPV 保护人群。
这项集群随机试验比较 9 至 10 岁与 11 至 12 岁启动接种的表现,13 岁前完成率更高,可帮助评估接种策略调整。
Introducing the human papillomavirus (HPV) vaccine at ages 9 to 10 years rather than 11 to 12 years leads to a meaningful difference in initiation and completion of the vaccine series, including initiation and completion by age 13 years, according to a study presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 21 to 24 in Washington, D.C.
Sean O'Leary, M.D., M.P.H., from the University of Colorado Denver Anschutz Medical Campus and Children's Hospital Colorado in Aurora, and colleagues examined the impact of switching HPV vaccine initiation from 11 to 12 years to 9 to 10 years in a cluster-randomized trial among 31 pediatric practices in Colorado and California from 2021 to 2026. Sixteen practices were randomly assigned to introduce the vaccine at ages 9 to 10 years and 15 practices at ages 11 to 12 years.
The researchers found that the median age at initiation and completion of the series was 11.0 and 12.2 years and 11.8 and 13.3 years in the 9- to 10-year-old arm and 11- to 12-year-old arm, respectively.
By age 13 years, 77.1% and 61.6% of adolescents had initiated and completed the series, respectively, in the 9- to 10-year-old arm compared with 67.0% and 45.1%, respectively, in the 11- to 12-year-old arm (adjusted hazard ratios for initiation and completion, 2.52 and 2.85, respectively, for 9 to 10 years versus 11 to 12 years).
"Lowering the age of vaccination holds promise for increasing the number of people protected against HPV, particularly as related cancers are on the rise," O'Leary said in a statement.
Who's behind this story?
Gaby Clark
MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
© 2026 HealthDay. All rights reserved.
Citation: IDSA: Earlier introduction of HPV vaccine improves initiation, completion by age 13 (2026, October 27) retrieved 27 October 2026 from https://medicalxpress.com/news/2026-10-idsa-earlier-introduction-hpv-vaccine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com